Since 2015, the company has been offering an accelerator program for the fields of life science, performance materials and healthcare. In a study, the young program was compared in terms of awareness with other established formats in the field of healthcare and has already reached an international second place.
The latest edition of the mHealth App Developer Economics 2017, which is the largest global study on mobile and digital health apps, found that 26.7% of the app publishers surveyed know about our Accelerator format. The findings are part of Research2Guidance’s mHealth Economics program, the largest global study on mobile and digital health apps. Research2Guidance regularly conducts research and publishes reports on the mobile app economy, market trends, and future market developments.
The results relate to responses submitted by 2400 participants in a survey on the digital global health community and show that we are especially popular across hi-tech industries. We are overwhelmed that our format even beats the equivalents of Samsung, Bayer, and Barclays in popularity.
Together with growing numbers of applications for the Accelerator, which reached a new peak in the current season, it makes us proud to see how much this format is being recognised among industry experts across the world. This high level of acknowledgement is undoubtedly related to the high quality of the startups that have applied and graduated from the Accelerator so far. Thanks to their innovative ideas together with great disruptive potential, startups like Sulfotools (Clean Peptide Technology), INURU (smart packaging), and many more were able to break through and persist.
We want to take this opportunity to encourage founders in life sciences, performance materials, healthcare, or additional research fields, to take the chance and boost their business together with us. We believe in permanent improvement of people’s lives and therefore aim to reshape relevant industries. If you work on innovative technology as for example laboratory supplies for biotech production, speciality chemicals, or pharmaceuticals, we want to help you bring it to the market.